CVNA: 63,750 shares proposed for sale by Morgan Stanley Smith Barney (CVNA)

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting the proposed sale of 63,750 shares of Common Stock. The filing states the shares arise from an exercise of stock options on 06/01/2026 and identifies $4,653,750.00 in aggregate proceeds tied to the position. The excerpt also lists three prior 10b5-1 sales by Mark Jenkins of 12,750 shares each on 03/02/2026, 04/01/2026, and 05/01/2026 with the reported proceeds for each sale.

Insights

Corporate Transactions Analyst

Notice filed for sale of exercised-option shares; prior 10b5-1 sales shown.

The filing documents a proposed resale of 63,750 shares derived from an exercise of stock options on 06/01/2026. The excerpt ties an aggregate figure of $4,653,750.00 to the position.

Three earlier automatic sales under a 10b5-1 plan by Mark Jenkins are listed (three tranches of 12,750 shares each on 03/02/2026, 04/01/2026, 05/01/2026). Cash-flow treatment and final sale timing are not specified in the excerpt; subsequent filings would show execution details.

Key Figures

Proposed shares to be sold: 63,750 shares Aggregate proceeds listed: $4,653,750.00 Outstanding/Reference count: 143,257,677 +4 more

7 metrics

Proposed shares to be sold 63,750 shares exercise of stock options on <date>06/01/2026</date>

Aggregate proceeds listed $4,653,750.00 figure associated with the position in the excerpt

Outstanding/Reference count 143,257,677 numeric value shown in the excerpt (06/01/2026)

Prior 10b5-1 sale (each tranche) 12,750 shares sales on <date>03/02/2026</date>, <date>04/01/2026</date>, <date>05/01/2026</date>

Proceeds — 05/01/2026 tranche $4,936,665.00 proceeds listed for the 05/01/2026 10b5-1 sale

Proceeds — 04/01/2026 tranche $3,956,931.20 proceeds listed for the 04/01/2026 10b5-1 sale

Proceeds — 03/02/2026 tranche $4,120,162.00 proceeds listed for the 03/02/2026 10b5-1 sale

Key Terms

Form 144, 10b5-1, exercise of stock options, aggregate proceeds

4 terms

Form 144 regulatory

"submitted a Form 144 notice reporting the proposed sale"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for MARK JENKINS"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

exercise of stock options financial

"Exercise of Stock Options | Issuer | 06/01/2026"

aggregate proceeds financial

"63750 | 4653750.00 | 143257677"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	63750	4653750.00	143257677	06/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Exercise of Stock Options	Issuer			63750	06/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	05/01/2026	12750	4936665.00
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	04/01/2026	12750	3956931.20
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	03/02/2026	12750	4120162.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CVNA's Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 63,750 shares arising from an exercise of stock options on 06/01/2026. It reports an associated aggregate figure of $4,653,750.00.

Were there recent insider sales related to CVNA reported in the excerpt?

Yes. The excerpt shows three 10b5-1 sales by Mark Jenkins of 12,750 shares each on 03/02/2026, 04/01/2026, and 05/01/2026, with proceeds listed per transaction.

Does the Form 144 specify how the shares will be sold for CVNA?

The excerpt indicates the shares stem from an exercise of stock options and lists Cash as consideration; specific distribution methods or timing are not detailed in the provided text.

Who is the filing agent or broker listed on the CVNA Form 144?

The excerpt lists Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004 as the filer for the proposed sale.